References
- Amidon, G. L., Lennernas, H., Shah, V. P., & Crison, J. R. (1995). A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailabitlity. Pharmaceutical Research, 12, 413–420., [PUBMED], [INFOTRIEVE], [CSA]
- Baumgartner, S., Smid-Korber, J., Vreces, F., & Kristl, J. (1998). Physical and technological parameters influencing floating properties of matrix tablets based on cellulose ethers. STP Pharma Sciences, 8, 182–187.
- Baumgartner, S., Kriste, J., & Zorko, B. (2000). Optimization of floating matrix tablets and evaluation of their gastric residence time. International Journal of Pharmaceutics, 195, 125–135., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brahma, N., & Kwon, H. K. (2000). Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. Journal of Controlled Release, 63, 235–259., [CSA], [CROSSREF]
- Davis, D. W. (1968, December 31). Method of Swallowing a Pill. US Patent 3,418,999.
- Desai, S., & Bolton, S. (1993). A floating controlled-release drug delivery system: in vitro-in vivo evaluation. Pharmaceutical Research 10, 1321–1325., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Deshpande, A. A., Rhodes, C. T., Shah, N. H., & Malick, A. W. (1996). Controlled release drug delivery systems for prolonged gastric residence: an overview. Drug Development and Industrial Pharmacy, 22, 531–539.
- Hwang, S. J., Park, H., & Park, K. (1998). Gastric retentive drug-delivery systems. Critical Reviews in Therapeutic Drug, 15, 243–284., [CSA]
- Melander, A., Stenberg, P., Liedholm, H., Schersten, B., & Wahlin-Boll, E. (1979). Food induced reduction in bioavailability of atenolol. European Journal of Clinical Pharmacology, 16, 327–330., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Michaels, A. S. (January 22, 1979). Drug Delivery Device with Self Actuated Mechanism for Retaining Device in Selected Area. US Patent 3,786,813.
- Oth, M., Franz, M., Timmermans, J., & Moes, A. (1992). The bilayer floating capsule: a stomach-directed drug delivery system for Misoprostol. Pharmaceutical Research, 9, 298–302., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rouge, N., Allermann, E., Gex-Fabry, M., Balant, L., Cole, E. T., Buri, P., & Doelker, E. (1998). Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharmaceutica Acta Helvetiae, 73, 81–87., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sheth, P. R., & Tossounian, J. (1978, November 21). Sustained Release Pharmaceutical Capsules. US Patent 4,126,672.
- Sheth, P. R., & Tossounian, J. L. (September 11, 1979). Novel Sustained Release Tablet Formulations. US Patent 4,167,558.
- Sheth, P. R., & Tossounian, J. (1994). The hydrodynamically balanced system (HBS): a novel drug delivery system for oral use. Drug Development and Industrial Pharmacy, 20, 313–339.
- Timmermans, J., & Moes, A. J. (1990). How well do floating dosage forms float? International Journal of Pharmaceutics, 62, 207–216., [CROSSREF]
- Watanabe, S., Kayano, M., Ishino, Y., Miyao, K. (August 24, 1976). Solid Therapeutic Preparation Remaining in Stomach. US Patent 3,976,764.